Skip to main content
. 2023 Jun 30;26(7):107231. doi: 10.1016/j.isci.2023.107231

Figure 5.

Figure 5

TSA treatment leads to a genomic redistribution of H3K9ac, H3K27ac and H3K27me3

(A) Scheme representing the strategy used in Min6 cells.

(B) Number of H3K9ac, H3K27ac and H3K27me3 peaks in vehicle- and TSA-treated Min6 cells.

(C–F) H3K9ac, H3K27ac and H3K27me3 signal in conserved active promoters (C), bivalent promoters (D), poised enhancers (E) and active enhancers (F) in vehicle- and TSA-treated Min6 cells. Heatmaps and mean signals centered on TSS +/−2.5 kb are represented.

See also Figures S3 and S4.